Related Experiment Video
Updated: Jul 25, 2026

In Situ Detection of Bacteria within Paraffin-embedded Tissues Using a Digoxin-labeled DNA Probe Targeting 16S rRNA
Published on: May 21, 2015
Akkermansia muciniphila Alleviates Porphyromonas gingivalis-induced Periodontal Disease by Enhancing Bacterial
Qin Hu1, Wai Keung Leung1, Aneesha Acharya1,2
1Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR, China.
Abstract:
This study is to investigate the role of Akkermansia muciniphila (Am) in enhancing immune defense against Porphyromonas gingivalis (Pg)-induced periodontal disease. Twenty C57BL/6 J mice received 50 µL of Pg suspension (1.5 × 109 CFU/mL) with or without 50 µL of Am suspension (1.5 × 109 CFU/mL) orally every 2 days for a total of 18 administrations to assess bone resorption and inflammation. Gingival cervical fluid and periodontal plaques were collected for microbiota analysis using 16S sequencing. THP-1 (a human leukemia monocytic cell line) differentiated macrophages were used to explore the underlying beneficial mechanisms of Am by evaluating gene expression, cytokine production, and phagocytosis activity. Am administration attenuated alveolar bone loss and reduced inflammation in Pg-induced periodontitis in mice. Microbiota analysis revealed that Am reduced bacterial load and modified the composition of periodontal microbiota. In THP-1 macrophages, Am enhanced the phagocytosis of Pg by restoring MyD88 protein levels. RNA sequencing and western blotting results showed that Am upregulated TLR2 and MyD88 expression while downregulating C5aR, indicating interference with the TLR2-C5aR-MyD88 interplay. Am enhances immune defense against Pg-induced periodontal disease by modulating the TLR2-C5aR-MyD88 signaling pathway. These findings suggest that Am could be a promising therapeutic option for managing periodontal disease.
Insights
Akkermansia muciniphila (Am) enhances immune defense against Porphyromonas gingivalis (Pg)-induced periodontal disease by modulating the TLR2-C5aR-MyD88 pathway. This suggests Am is a promising therapeutic option for periodontitis.
Area of Science:
- Microbiology
- Immunology
- Periodontology
Background:
- Periodontal disease is a common inflammatory condition often caused by Porphyromonas gingivalis (Pg).
- Akkermansia muciniphila (Am) is a gut bacterium with potential immunomodulatory effects.
Purpose of the Study:
- To investigate the role of Am in enhancing immune defense against Pg-induced periodontal disease.
- To explore the underlying mechanisms of Am's beneficial effects on periodontal health.
Main Methods:
- Mice were induced with periodontal disease using Pg and treated with or without Am.
- Gingival microbiota was analyzed using 16S sequencing.
- THP-1 derived macrophages were used to assess Am's effects on gene expression, cytokine production, and phagocytosis of Pg.
Main Results:
- Am administration attenuated alveolar bone loss and reduced inflammation in a mouse model of periodontitis.
- Microbiota analysis showed Am reduced bacterial load and altered periodontal microbial composition.
- Am enhanced Pg phagocytosis by macrophages and modulated the TLR2-C5aR-MyD88 signaling pathway.
Conclusions:
- Akkermansia muciniphila enhances immune defense against Porphyromonas gingivalis-induced periodontal disease.
- Am modulates the TLR2-C5aR-MyD88 signaling pathway, offering a potential therapeutic strategy for periodontitis.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
The Oral Microbiota
Development of the Oral Microbiota
Microbiota of the Respiratory Tract
Microbiota of the Urogenital Tract
Clinical Significance of Antibiotic Resistance

